Sidharth Chopra

A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents

Peter B. Madrid, Sidharth Chopra, Ian D. Manger et al. · PLoS ONE · 2013 · 254 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis

Sidharth Chopra, Kiminori Matsuyama, Thuy Tran et al. · Journal of Antimicrobial Chemotherapy · 2011 · 102 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Novel Chalcone–Thiazole Hybrids as Potent Inhibitors of Drug Resistant<i>Staphylococcus aureus</i>

Koneni V. Sashidhara, K. Bhaskara Rao, Pragati Kushwaha et al. · ACS Medicinal Chemistry Letters · 2015 · 75 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Identification of antimicrobial activity among FDA-approved drugs for combating Mycobacterium abscessus and Mycobacterium chelonae

Sidharth Chopra, Kiminori Matsuyama, Christina L. Hutson et al. · Journal of Antimicrobial Chemotherapy · 2011 · 75 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms.

Sidharth Chopra, Alan Rubinow, Raymond S. Koff et al. · PubMed · 1984 · 73 citations

Medicine, Biochemistry, Pathology +14